Literature DB >> 1271589

Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs.

I Azuma, K Sugimura, Y Yamamura, S Kusumoto, Y Tarumi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1271589     DOI: 10.1111/j.1348-0421.1976.tb00909.x

Source DB:  PubMed          Journal:  Jpn J Microbiol        ISSN: 0021-5139


× No keyword cloud information.
  10 in total

Review 1.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

2.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

3.  Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.

Authors:  H Ohkuni; Y Norose; M Ohta; M Hayama; Y Kimura; M Tsujimoto; S Kotani; T Shiba; S Kusumoto; K Yokogawa; S Kawata
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

4.  Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors:  I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

5.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.

Authors:  M F Powell; L C Foster; A R Becker; W Lee
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

6.  Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation.

Authors:  Z Zídek; K Masek; F Sedivý
Journal:  Agents Actions       Date:  1984-01

7.  Relationship of anti-tuberculous protection to lung granuloma produced by intravenous injection of synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with or without specific antigens.

Authors:  K Yamamoto; M Kakinuma; K Kato; H Okuyama; I Azuma
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

8.  Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.

Authors:  K Matsumoto; H Ogawa; T Kusama; O Nagase; N Sawaki; M Inage; S Kusumoto; T Shiba; I Azuma
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.

Authors:  M A Parant; F M Audibert; L A Chedid; M R Level; P L Lefrancier; J P Choay; E Lederer
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

10.  Macrophage activation by bacterial cell walls and related synthetic compounds.

Authors:  H Takada; M Tsujimoto; K Kato; S Kotani; S Kusumoto; M Inage; T Shiba; I Yano; S Kawata; K Yokogawa
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.